Nasal dressings have frequently been advocated to improve wound healing and prevent ongoing bleeding after endoscopic sinus surgery (ESS). Initial experience focused on removable nasal packing materials; however, their adverse effect profile, such as pain/discomfort and mucosal trauma, has driven the development of absorbable biomaterials. Despite these developments, there is still little agreement on the optimal choice of nasal dressing or whether nasal dressings are required at all
Does percutaneous endoscopic gastrostomy (PEG) use cause dysphagia in head and neck cancer patients? Background: PEG use is common in patients who undergo radiotherapy for head and neck cancer to […]
What would be a good surgical technique for the treatment of nasal septal perforations with diameters of 1 to 2 cm? Background: Surgical therapy is required for nasal septal perforation, […]
Can a clinically aligned, reproducible model for subglottic injury be developed? Background: Animal models for subglottic stenosis (SGS) have been invaluable in understanding the underlying mechanisms and in developing new […]
What are the associations between findings from drug-induced sleep endoscopy (DISE) and lateral cephalometry in obstructive sleep apnea (OSA)? Background: Because surgical treatment of OSA is directed at specific regions […]
What is the impact of personal music players, earphones and music styles on output and preferred listening levels (PLL)? Background: In the U.S., more than 48 percent of the general […]
Can the effect of propranolol on infantile hemangiomas be quantified? Background: The utilization of propranolol for the treatment of infantile hemangiomas is efficacious and is considered the first-line treatment. Many […]
Does the administration of systemic steroids during the post-operative course affect the morbidity associated with tonsillectomy surgery? Background: Tonsillectomy is one of the most common surgical procedures performed in North […]
Long-duration therapy with macrolide antibiotics has been advocated for the treatment of recalcitrant chronic rhinosinusitis (CRS). However, uncertainty exists as to which patients will respond to such treatment, the degree of benefit likely to be obtained, and the relevant risks to the patient and community at large
Chronic cough affects countless patients worldwide, but hasn’t been a traditional focus of the ENT physician community